共 50 条
- [41] NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (07): : 685 - 686
- [42] Practice considerations for behavioral therapies for depression and anxiety in midlife women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (02): : 236 - 238
- [45] Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife AMERICAN JOURNAL OF MEDICINE, 2006, 119 (09): : 94 - 102
- [46] Paroxetine versus placebo for women in midlife after hormone therapy discontinuation AMERICAN JOURNAL OF MEDICINE, 2008, 121 (02): : 159 - U12
- [48] Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife AMERICAN JOURNAL OF MEDICINE, 2006, 119 (09): : 87 - 93
- [50] Antimullerian hormone and adiposity across midlife among women in Project Viva MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (03): : 247 - 253